Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.

Crataeva nurvala leaves may help reduce anxiety and improve sleep.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Certain hormone treatments can improve acne and related conditions in women.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Baricitinib and ritlecitinib are both effective and safe for treating severe alopecia areata.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

Ritlecitinib helps adolescents with severe alopecia areata regrow scalp hair and normalize body hair and nails.

Certain compounds from Stephania cepharantha help hair cell growth.

The lotion with N793 strain significantly increased hair density and reduced hair loss safely.

Platycladi Cacumen may help treat hair loss by affecting certain biological pathways.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.